Pharma-Bio Serv (PBSV) Cash from Investing Activities (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Cash from Investing Activities came in at -$1.9 million in Q2 2026, up 41.52% YoY from -$1.3 million in Q2 2025, and down 168.21% on a QoQ basis from $2.8 million in Q1 2026.
Pharma-Bio Serv (PBSV) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 17 years of Cash from Investing Activities data on file, last reported at -$1.9 million in Q2 2026.
- Quarterly Cash from Investing Activities rose 41.52% year-over-year to -$1.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.7 million (up 1.77% YoY) and the FY2025 annual result came in at -$1.5 million, down 7.75% from the prior year.
- Cash from Investing Activities fell to -$1.9 million in Q2 2026, from $2.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $7.3 million in Q4 2023 to a low of -$8.2 million in Q1 2023.
- A 5-year average of -$343625.2 and a median of -$3224.0 in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 65099.47% in 2023, down 1199309.94% in 2023.
- Tracing PBSV's Cash from Investing Activities over 5 years: stood at -$12137.0 in 2022, then jumped by 60469.54% to $7.3 million in 2023, then slumped by 97.66% to $171532.0 in 2024, then slumped by 599.42% to -$856665.0 in 2025, then plunged by 120.29% to -$1.9 million in 2026.
- The last three Cash from Investing Activities figures came in at -$1.9 million (Q2 2026), $2.8 million (Q1 2026), and -$856665.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -388.71 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -28.20 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -13.90 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -7.74 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 28.62 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -56.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -69.60 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 112.99 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.89 Mn |
| Apr 30, 2026 | -1.89 Mn |
| Jan 31, 2026 | 2.77 Mn |
| Jan 31, 2026 | 2.77 Mn |
| Oct 31, 2025 | -856,665.00 |
| Oct 31, 2025 | -856,665.00 |
| Jul 31, 2025 | 1.63 Mn |
| Jul 31, 2025 | 1.63 Mn |
| Apr 30, 2025 | -3.23 Mn |
| Apr 30, 2025 | -3.23 Mn |
| Jan 31, 2025 | 988,338.00 |
| Jan 31, 2025 | 988,338.00 |
| Oct 31, 2024 | 171,532.00 |
| Oct 31, 2024 | 171,532.00 |
| Jul 31, 2024 | 3.69 Mn |
| Jul 31, 2024 | 3.69 Mn |
| Apr 30, 2024 | -458,942.00 |
| Apr 30, 2024 | -458,942.00 |
| Jan 31, 2024 | -4.76 Mn |
| Jan 31, 2024 | -4.76 Mn |